Key facts
- It has raised $4.7M; the latest was Early Stage VC ($4.7M) in Feb 2026.
- Notable investors include NLC Health Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Sigilla Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Sigilla Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sigilla Medical
Developer of implant-free cardiac radiofrequency devices designed for the closure of intracardiac defects associated with stroke risk. The company provides minimally invasive system applies controlled radiofrequency energy to seal the defect without leaving a permanent implant, reduces the need for large metal devices spanning the cardiac septum in otherwise young and healthy patients, lowers procedural complications and adverse cardiac events, preserves cardiac anatomy for future minimally invasive interventions, enabling interventional cardiology providers to treat stroke-risk and migraine-associated defect patients with a safer, less-invasive and more efficient alternative.
- Sector
- Healthcare
- HQ
- Dublin, Ireland
- Founded
- 2024
- Website
- sigillamedical.com/
- Ownership
- Privately Held (backing)
Sigilla Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sigilla Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sigilla Medical in its N-PORT filings yet. We sweep new filings monthly.